However, this transporter is also implicated in immune function, as a too high expression (as seen in tumor cells) reduces the availability of methionine for T cells, and downregulation of SLC43A2 can boost spontaneous and checkpoint-induced tumor immunity [35]. This evidence concerns the gene SLC43A2 and neoplasm.